22.03.2012 - GlaxoSmithKline and rivals including Pfizer are preparing second-round bids for Turkey's Mustafa Nevzat Ilac Sanayi, a maker of injectable generic drugs, that may be worth as much...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)